Article Information
PubMed
History
- Published online February 4, 2013.
Article Versions
- Latest version (November 26, 2012 - 08:19).
- Latest version (January 21, 2013 - 08:32).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 Canadian Medical Association or its licensors
Author Information
- Tara Gomes, MHSc⇑,
- Muhammad M. Mamdani, PharmD MPH,
- Anne M. Holbrook, MD PharmD,
- J. Michael Paterson, MSc,
- Chelsea Hellings, MSc,
- David N. Juurlink, MD PhD
- The Leslie Dan Faculty of Pharmacy (Gomes, Mamdani) and the Department of Health Policy, Management, and Evaluation (Juurlink, Mamdani, Paterson), University of Toronto; the Institute for Clinical Evaluative Sciences (Juurlink, Paterson, Hellings, Mamdani); the Sunnybrook Research Institute (Juurlink); and the Keenan Research Centre of the Li Ka Shing Knowledge Institute (Mamdani), St. Michael’s Hospital, Toronto, Ont.; the Department of Family Medicine (Paterson) and Division of Clinical Pharmacology & Therapeutics (Holbrook), McMaster University; and the Centre for Evaluation of Medicines (Holbrook, Paterson), St. Joseph’s Healthcare, Hamilton, Ont.
- Correspondence to:
Tara Gomes, tara.gomes{at}ices.on.ca
Cited By...
In this issue
Article tools
Respond to this article
Rates of hemorrhage during warfarin therapy for atrial fibrillation
Jump to section
Related Articles
Cited By...
- Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
- Cardioembolic stroke: everything has changed
- Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF
- Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
- Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery
- Clinical Application of Prothrombin Complex Concentrate in Blood Management in Patients
- Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation
- Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective--2016 Update
- Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
- Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review
- Adherence to oral anticoagulants in patients with atrial fibrillation--a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol
- Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation
- The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
- Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting
- Use of blood products in patients with anticoagulant-related major bleeding: An analysis of inhospital outcomes
- Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention: A Contemporary Review
- Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
- Warfarin and absolute risk of hemorrhagic stroke
More in this TOC Section
Similar Articles
Collections
